Lisa J. Christopher

1.1k citations

41 papers · 897 indexed · h-index 15

Co-authors: W. Griffith Humphreys Ramaswamy A. Iyer David W. Boulton Donghui Cui Samuel J. Bonacorsi Michael W. Lago Mark E. Arnold Kan He
Topics: Pharmacogenetics and Drug Metabolism (9 papers)Drug Transport and Resistance Mechanisms (9 papers)Chronic Myeloid Leukemia Treatments (7 papers)
Cited by: Pharmacology Hematology Genetics
Journals: Scientific Reports Journal of Medicinal Chemistry Journal of Pharmaceutical Sciences
Partner nations: United States Germany Sweden

In The Last Decade

Lisa J. Christopher

40 papers receiving 861 citations

Peers

Countries citing papers authored by Lisa J. Christopher

Since Specialization

Citations

This map shows the geographic impact of Lisa J. Christopher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa J. Christopher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa J. Christopher more than expected).

Fields of papers citing papers by Lisa J. Christopher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa J. Christopher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa J. Christopher. The network helps show where Lisa J. Christopher may publish in the future.

Co-authorship network of co-authors of Lisa J. Christopher

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa J. Christopher. A scholar is included among the top collaborators of Lisa J. Christopher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa J. Christopher. Lisa J. Christopher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Itraconazole and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Milvexian, A Factor XIa Inhibitor 2022 ·Cardiology and Therapy ·Vidya Perera,Zhaoqing Wang,(unknown),Lisa J. Christopher,Wei Chen,(unknown),Dietmar Seiffert,Mary M. DeSouza,Bindu Murthy	18
2	Prediction of drug–drug interaction potential mediated by transporters between dasatinib and metformin, pravastatin, and rosuvastatin using physiologically based pharmacokinetic modeling 2022 ·Cancer Chemotherapy and Pharmacology ·Ming Chang,Sai Praneeth Bathena,Lisa J. Christopher,Hong Shen,Amit Roy	9
3	Effects of rifampin on the pharmacokinetics and pharmacodynamics of milvexian, a potent, selective, oral small molecule factor XIa inhibitor 2022 ·Scientific Reports ·Vidya Perera,Zhaoqing Wang,(unknown),Lisa J. Christopher,Wei Chen,(unknown),Dietmar Seiffert,Mary M. DeSouza,Bindu Murthy	12
4	Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition 2018 ·Drug Metabolism and Disposition ·Hong Shen,Lisa J. Christopher,Yurong Lai,Jiachang Gong,Hamza Kandoussi,Samira M. Garonzik,Vidya Perera,Τushar Garimella,W. Griffith Humphreys	50
5	Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression 2015 ·Drug Metabolism and Disposition ·Hong Shen,(unknown),Bridget L. Morse,Yue Zhao,Yueping Zhang,Xi Qiu,Cliff Chen,Anne Lewin,Xitao Wang,Guowen Liu,Lisa J. Christopher,Punit Marathe,Yurong Lai	72
6	Characterization of the In Vitro and In Vivo Metabolism and Disposition and Cytochrome P450 Inhibition/Induction Profile of Saxagliptin in Human 2012 ·Drug Metabolism and Disposition ·Hong Su,David W. Boulton,(unknown),Lifei Wang,Kai Cao,Samuel J. Bonacorsi,Ramaswamy A. Iyer,W. Griffith Humphreys,Lisa J. Christopher	41
7	Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: Method validation and overcoming specific and non-specific binding at low concentrations 2012 ·Journal of Chromatography B ·Xiaohui Xu,(unknown),Huidong Gu,Lisa J. Christopher,Hong Su,Laura Cojocaru,David W. Boulton,Mark Kirby,Bruce Stouffer,W. Griffith Humphreys,Mark E. Arnold	32
8	Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans 2011 ·Drug Metabolism and Disposition ·Jiachang Gong,Jinping Gan,Janet Caceres‐Cortes,Lisa J. Christopher,Vinod Arora,Eric Masson,(unknown),Janice Pursley,Alban J. Allentoff,Michael W. Lago,(unknown),Ramaswamy A. Iyer	13
9	In Vitro Characterization of the Metabolic Pathways and Cytochrome P450 Inhibition and Induction Potential of BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor 2011 ·Drug Metabolism and Disposition ·Haizheng Hong,Hong Su,Li Ma,Ming Yao,Ramaswamy A. Iyer,W. Griffith Humphreys,Lisa J. Christopher	10
10	Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-690514, a Potent Inhibitor of EGFR and VEGFR2 2010 ·Journal of Pharmaceutical Sciences ·Punit Marathe,(unknown),Bogdan Sleczka,David Rodrigues,Ashvinikumar V. Gavai,Tai‐Tong Wong,Lisa J. Christopher,Hongjian Zhang	16
11	Development and evaluation of a multiple-plate fraction collector for sample processing: Application to radioprofiling in drug metabolism studies 2010 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown),(unknown),Theodore J. Chando,Qian Ruan,(unknown),(unknown),Lisa J. Christopher	4
12	Metabolism and Disposition of [14C]BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor, after Oral Administration to Humans 2010 ·Drug Metabolism and Disposition ·Lisa J. Christopher,Haizheng Hong,Blisse Vakkalagadda,Pamela L. Clemens,Hong Su,Vikram Roongta,Alban J. Allentoff,(unknown),Kevin N. Heller,Christopher Harbison,Ramaswamy A. Iyer,W. Griffith Humphreys,Tai‐Tong Wong,Steven Zhang	16
13	Metabolism and Disposition of [14C]BMS-690514 after Oral Administration to Rats, Rabbits, and Dogs 2010 ·Drug Metabolism and Disposition ·Haizheng Hong,Hong Su,(unknown),Alban J. Allentoff,(unknown),Theodore J. Chando,Janet Caceres‐Cortes,Vikram Roongta,Ramaswamy A. Iyer,W. Griffith Humphreys,Lisa J. Christopher	4
14	Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections 2009 ·Drug Metabolism and Disposition ·Aberra Fura,Ashish K. Khanna,Viral Vyas,Barry Koplowitz,Shu‐Ying Chang,(unknown),David W. Boulton,Lisa J. Christopher,(unknown),Lawrence G. Hamann,W. Griffith Humphreys,Mark Kirby	86
15	Lacteal Secretion, Fetal and Maternal Tissue Distribution of Dasatinib in Rats 2008 ·Drug Metabolism and Disposition ·Kan He,Michael W. Lago,Ramaswamy A. Iyer,(unknown),W. Griffith Humphreys,Lisa J. Christopher	43
16	Metabolism and Disposition of Dasatinib after Oral Administration to Humans 2008 ·Drug Metabolism and Disposition ·Lisa J. Christopher,Donghui Cui,Chi‐Yuan Wu,Roger Luo,James Manning,Samuel J. Bonacorsi,Michael W. Lago,Alban J. Allentoff,Francis Y. F. Lee,(unknown),Susan Galbraith,Donald P. Reitberg,Kan He,(unknown),Anne Blackwood‐Chirchir,W. Griffith Humphreys,Ramaswamy A. Iyer	158
17	Identification of the Human Enzymes Involved in the Oxidative Metabolism of Dasatinib: An Effective Approach for Determining Metabolite Formation Kinetics 2008 ·Drug Metabolism and Disposition ·Lifei Wang,Lisa J. Christopher,Donghui Cui,Wenying Li,Ramaswamy A. Iyer,W. Griffith Humphreys,Donglu Zhang	58
18	CYP2D6 CATALYZES 5-HYDROXYLATION OF 1-(2-PYRIMIDINYL)-PIPERAZINE, AN ACTIVE METABOLITE OF SEVERAL PSYCHOACTIVE DRUGS, IN HUMAN LIVER MICROSOMES 2004 ·Drug Metabolism and Disposition ·Nirmala Raghavan,Donglu Zhang,Mingshe Zhu,Jianing Zeng,Lisa J. Christopher	9
19	Effect of a High‐Fat Meal on the Pharmacokinetics of the Des‐F(6)‐Quinolone BMS‐284756 2002 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown),(unknown),Akintunde Bello,Zhiyu Ge,Lisa J. Christopher,Dennis M. Grasela	11
20	6-Acylamino-2-[(alkylsulfonyl)oxy]-1H-isoindole-1,3-dione mechanism-based inhibitors of human leukocyte elastase 2000 ·Bioorganic & Medicinal Chemistry Letters ·John E. Kerrigan,(unknown),(unknown),(unknown),Lisa J. Christopher	12

About Lisa J. Christopher

Lisa J. Christopher is a scholar working on Pharmacology, Genetics and Oncology, having authored 41 papers that have together received 897 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). The work is most often cited by research in Pharmacology (181 citations), Hematology (191 citations) and Genetics (163 citations). Lisa J. Christopher has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include W. Griffith Humphreys, Ramaswamy A. Iyer, David W. Boulton, Donghui Cui, Samuel J. Bonacorsi, Michael W. Lago, Mark E. Arnold, Kan He, Xiaohui Xu and Hong Shen. Their work appears in journals such as Scientific Reports, Journal of Medicinal Chemistry and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact